Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for metabolic diseases, has announced its presentation schedule for May 2025 ...

About Aardvark Therapeutics, Inc. Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of PWS and ...

About Aardvark Therapeutics, Inc. Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of PWS and ...

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic ...

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Aardvark Therapeutics, Inc. before investing. In this article, we go over a few ...

Welcome to the new I Found the Aardvark points page! On this page you will be able to log your aardvark finds and gain points which can then be spent on great aardvark gear! Total Number of Hunters: ...

At close: May 13 at 4:00:02 PM EDT ...